These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3022620)

  • 1. Opiate antagonist in traumatic shock.
    McIntosh TK; Faden AI
    Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 5. Opiate antagonists in shock and trauma.
    Holaday JW
    Am J Emerg Med; 1984 Jan; 2(1):8-12. PubMed ID: 6097276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioids in spinal cord injury: a critical evaluation.
    Long JB; Martinez-Arizala A; Petras JM; Holaday JW
    Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists.
    Faden AI; Holaday JW
    J Infect Dis; 1980 Aug; 142(2):229-38. PubMed ID: 6251139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in spinal cord injury: comparative experimental models.
    Faden AI; Jacobs TP; Smith GP; Green B; Zivin JA
    Peptides; 1983; 4(5):631-4. PubMed ID: 6657511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor dysfunction after spinal cord injury is mediated by opiate receptors.
    Faden AI; Knoblach S; Mays C; Jacobs TP
    Peptides; 1985; 6 Suppl 1():15-7. PubMed ID: 2995941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat.
    McIntosh TK; Fernyak S; Hayes RL; Faden AI
    J Neurotrauma; 1993; 10(4):373-84. PubMed ID: 8145261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
    Faden AI
    Cent Nerv Syst Trauma; 1985; 2(1):5-8. PubMed ID: 3004747
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone.
    Faden AI; Hallenbeck JM; Brown CQ
    Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting actions of naloxone in experimental spinal cord trauma and cerebral ischemia: a review.
    Hamilton AJ; Black PM; Carr DB
    Neurosurgery; 1985 Nov; 17(5):845-9. PubMed ID: 2999639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate antagonist improves neurologic recovery after spinal injury.
    Faden AI; Jacobs TP; Holaday JW
    Science; 1981 Jan; 211(4481):493-4. PubMed ID: 7455690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endorphins in experimental spinal injury: therapeutic effect of naloxone.
    Faden AI; Jacobs TP; Mougey E; Holaday JW
    Ann Neurol; 1981 Oct; 10(4):326-32. PubMed ID: 6274252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury.
    Faden AI; Jacobs TP; Smith MT; Holaday JW
    Neurology; 1983 Jun; 33(6):673-8. PubMed ID: 6405303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock.
    Faden AI
    JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
    Holaday JW; Ruvio BA; Faden AI
    Eur J Pharmacol; 1981 Aug; 74(1):101-5. PubMed ID: 6797829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
    Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
    Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.